Bill is co-founder of Argus Farm Stop, L3C, an Ann Arbor based initiative to grow the local food economy, which has paid out over $5 million to local farms/producers since 2014. Bill also has more than 25 years of experience in the pharmaceutical and biotech industry and is currently CEO of EVOQ Therapeutics. He was previously president of AlphaCore Pharma prior to the company’s acquisition by Astra Zeneca in 2013, co-founder and chief operating officer of Cerenis Therapeutics from 2005-2011 and vice president of business development at Esperion Therapeutics, overseeing all strategic partnering activities prior to the company’s acquisition by Pfizer. Prior to joining Esperion, he oversaw U.S. business development, market planning and sales operations for Sankyo, a leading Japanese pharmaceutical company (now Daiichi Sankyo). Bill holds a master’s degree in business administration as well as bachelors and master’s degrees in industrial and operations engineering from the University of Michigan.